GSP Crop Science IPO Allotment Status: Check Latest Updates and GMP
GSP Crop Science IPO share allotment is expected to be finalised on March 20. Here’s how to check the allotment status on the registrar, BSE, and NSE websites.
Blog
Blog
Pilgrims Pride Corp Hits 52-Week Low: What Indian Investors Should Know
Pilgrims Pride Corp stock has hit a 52-week low at $35.71. Understand the implications for Indian investors and the broader market trends.
Blog
SailPoint Technologies Holdings Inc. (NASDAQ:SAIL) Price Target Lowered by Royal Bank Of Canada to $19.00
Royal Bank Of Canada lowers price target for SailPoint Technologies Holdings Inc. (NASDAQ:SAIL) to $19.00, suggesting a potential upside of 50.03% from the company’s previous close.
Blog
SailPoint Stock Price Target Lowered by Scotiabank: What Indian Investors Need to Know
Get the latest updates on SailPoint’s stock price target reduction by Scotiabank and its implications for Indian investors.
Blog
SailPoint Technologies: Analysts Cut Price Target, But Upside Potential Remains
SailPoint Technologies Holdings, Inc (NASDAQ:SAIL) had its target price cut by stock analysts at Royal Bank Of Canada, but the company still holds upside potential for investors.
Blog
Sherwin-Williams Price Target Lowered: What Indian Investors Need to Know
Royal Bank Of Canada lowers price target for Sherwin-Williams to $376.00, citing potential upside of 23.24%. What does this mean for Indian investors?
Blog
IMF Warns of Prolonged Energy Price Hike Impact on Global Economy
The International Monetary Fund (IMF) has warned that a prolonged increase in energy prices could lead to higher inflation and lower economic growth globally, and what this means for Indian investors and traders.
Blog
AppLovin Stock Pulls Back: What Indian Investors Need to Know
AppLovin Corp shares are trading lower due to insider transactions and broader tech sector weakness. What does this mean for Indian investors?
Blog
Sarepta Stock Underperform Rating Reiterated by BofA: What Indian Investors Need to Know
Bank of America (BofA) has reiterated its Underperform rating on Sarepta Therapeutics stock, citing regulatory risks. What does this mean for Indian investors and how can they navigate the complex landscape of international stocks?
Blog
Is Deregulation to Blame for India’s Energy Woes?
India’s energy sector is facing a crisis, with many blaming deregulation for the woes. But is deregulation really to blame, or are there other factors at play?